Psyadon Pharmaceuticals

Acquired

Germantown, United States · Founded 2004 · $8.0M raised

Employees
1–10
Founded
2004
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Venture RoundAug 2018
Rounds
2

About

Psyadon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments for rare and serious neurological disorders, most notably Tourette syndrome. The company has conducted clinical trials for ecopipam, a selective dopamine D1/D5 receptor antagonist being investigated as a potential treatment for Tourette syndrome in both pediatric and adult populations. Based in Germantown, Maryland, Psyadon operates as a small, focused drug development organization targeting underserved CNS conditions where current treatment options remain limited.

Summary

Psyadon Pharmaceuticals is a Biotech company based in Germantown, United States, founded in 2004. It has raised $8.0M in total across 2 rounds, most recently a $8.0M Venture Round round in Aug 2018. Investors include New Enterprise Associates, Alexandria Venture Investments and Pfizer Ventures.

Funding History

Venture RoundVenture RoundAug 2018

Sign up to see all 2 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Psyadon Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/psyadon-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/psyadon-pharmaceuticals" alt="Psyadon Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>